- Home
- COCH vs TPST Comparison
COCH vs TPST Comparison
Compare COCH & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COCH
- TPST
- Stock Information
- Founded
- COCH 1995
- TPST 2011
- Country
- COCH United States
- TPST United States
- Employees
- COCH N/A
- TPST N/A
- Industry
- COCH Blank Checks
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- COCH Finance
- TPST Health Care
- Exchange
- COCH Nasdaq
- TPST Nasdaq
- Market Cap
- COCH 31.6M
- TPST 33.0M
- IPO Year
- COCH N/A
- TPST N/A
- Fundamental
- Price
- COCH $1.50
- TPST $7.50
- Analyst Decision
- COCH Strong Buy
- TPST Hold
- Analyst Count
- COCH 2
- TPST 3
- Target Price
- COCH $9.25
- TPST $30.00
- AVG Volume (30 Days)
- COCH 19.6K
- TPST 234.4K
- Earning Date
- COCH 08-11-2025
- TPST 08-07-2025
- Dividend Yield
- COCH N/A
- TPST N/A
- EPS Growth
- COCH N/A
- TPST N/A
- EPS
- COCH N/A
- TPST N/A
- Revenue
- COCH $212,000.00
- TPST N/A
- Revenue This Year
- COCH $8.04
- TPST N/A
- Revenue Next Year
- COCH $15.39
- TPST N/A
- P/E Ratio
- COCH N/A
- TPST N/A
- Revenue Growth
- COCH N/A
- TPST N/A
- 52 Week Low
- COCH $1.21
- TPST $5.35
- 52 Week High
- COCH $3.99
- TPST $30.03
- Technical
- Relative Strength Index (RSI)
- COCH 57.76
- TPST 57.03
- Support Level
- COCH $1.40
- TPST $7.06
- Resistance Level
- COCH $1.58
- TPST $7.18
- Average True Range (ATR)
- COCH 0.08
- TPST 0.27
- MACD
- COCH 0.01
- TPST 0.05
- Stochastic Oscillator
- COCH 100.00
- TPST 86.58
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.